Jordan Mark Barrows

Jordan Mark Barrows

Auto-generated profile, based on publicly available information

Jordan Mark Barrows

Johns Hopkins University School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2020 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
JBJordan M. Barrows
Jordan M. Barrows
EGErin D. Goley
Erin D. Goley

10 June 2019 in eLife
Verified
Journal Article
Open access
EMErnesto Manzo
Ernesto Manzo
ILIleana Lorenzini
Ileana Lorenzini
DBDianne Barrameda
Dianne Barrameda
AOAbigail G O'COnner
Abigail G O'COnner
JBJordan M Barrows
Jordan M Barrows
DZDaniela Zarnescu
Daniela Zarnescu
Amyotrophic Lateral Sclerosis (ALS), is a fatal neurodegenerative disorder, with TDP-43 inclusions as a major pathological hallmark. Using a Drosophila model of TDP-43 proteinopathy we found significant alterations in glucose metabolism including increased pyruvate, suggesting that modulating glycolysis may be neuroprotective. Indeed, a high sugar diet improves locomotor and lifespan defects caused by TDP-43 proteinopathy in motor neurons or glia, but not muscle, suggesting that metabolic dysregulation occurs in the nervous system. Overexpressing human glucose transporter GLUT-3 in motor neurons mitigates TDP-43 dependent defects in synaptic vesicle recycling and improves locomotion. Furthermore, PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology. Surprisingly, PFK overexpression rescues TDP-43 induced locomotor deficits. These findings from multiple ALS models show that mechanistically, glycolysis is upregulated in degenerating motor neurons as a compensatory mechanism and suggest that increased glucose availability is protective.

31 May 2018 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
EMErnesto Manzo
Ernesto Manzo
AOAbigail G. O'Conner
Abigail G. O'Conner
JBJordan M. Barrows
Jordan M. Barrows
DSDakotah D. Shreiner
Dakotah D. Shreiner
GBGabriel J. Birchak
Gabriel J. Birchak
DZDaniela Zarnescu
Daniela Zarnescu
ALS patients exhibit dyslipidemia, hypermetabolism and weight loss; in addition, cellular energetics deficits have been detected prior to denervation. Although evidence that metabolism is altered in ALS is compelling, the mechanisms underlying metabolic dysregulation and the contribution of altered metabolic pathways to disease remain poorly understood. Here we use a Drosophila model of ALS based on TDP-43 that recapitulates hallmark features of the disease including locomotor dysfunction and reduced lifespan. We performed a global, unbiased metabolomic profiling of larvae expressing TDP-43 (wild-type, TDPWT or disease-associated mutant, TDPG298S) and identified several lipid metabolism associated alterations. Among these, we found a significant increase in carnitine conjugated long-chain fatty acids and a significant decrease in carnitine, acetyl-carnitine and beta-hydroxybutyrate, a ketone precursor. Taken together these data suggest a deficit in the function of the carnitine shuttle and reduced lipid beta oxidation. To test this possibility we used a combined genetic and dietary approach in Drosophila. Our findings indicate that components of the carnitine shuttle are misexpressed in the context of TDP-43 proteinopathy and that genetic modulation of CPT1 or CPT2 expression, two core components of the carnitine shuttle, mitigates TDP-43 dependent locomotor dysfunction, in a variant dependent manner. In addition, feeding medium-chain fatty acids or beta-hydroxybutyrate improves locomotor function, consistent with the notion that bypassing the carnitine shuttle deficit is neuroprotective. Taken together, our findings highlight the potential contribution of the carnitine shuttle and lipid beta oxidation in ALS and suggest strategies for therapeutic intervention based on restoring lipid metabolism in motor neurons.

22 February 2023 in Journal of Bacteriology
Verified
Journal Article
Closed access
JBJordan M. Barrows
Jordan M. Barrows
EGErin D. Goley
Erin D. Goley
First isolated and classified in the 1960s, Caulobacter crescentus has been instrumental in the study of bacterial cell biology and differentiation. C. crescentus is a Gram-negative alphaproteobacterium that exhibits a dimorphic life cycle composed of two distinct cell types: a motile swarmer cell and a nonmotile, division-competent stalked cell. Progression through the cell cycle is accentuated by tightly controlled biogenesis of appendages, morphological transitions, and distinct localization of developmental regulators.

11 March 2020 in Journal of Bacteriology
Verified
Journal Article
Closed access
JBJordan M. Barrows
Jordan M. Barrows
KSKousik Sundararajan
Kousik Sundararajan
ABAnant Bhargava
Anant Bhargava
EGErin D. Goley
Erin D. Goley
Bacterial cell division is essential and requires the recruitment and regulation of a complex network of proteins needed to initiate and guide constriction and cytokinesis. FtsZ serves as a master regulator for this process, and its function is highly dependent on both its assembly into the canonical Z ring and interactions with protein binding partners, all of which results in the activation of enzymes that remodel the cell wall to drive constriction. Using mutants of FtsZ, we have elaborated on the role of its C-terminal linker domain in regulating Z-ring stability and dynamics, as well as the requirement for its conserved C-terminal domain and interaction with the membrane-anchoring protein FtsA for regulating the process of cell wall remodeling for constriction.

28 November 2023 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CMChristopher R. Mahone
Christopher R. Mahone
IPIsaac P. Payne
Isaac P. Payne
Zhixin (Jason) LyuZhixin (Jason) Lyu
Zhixin (Jason) Lyu
JMJoshua W. McCausland
Joshua W. McCausland
JBJordan M. Barrows
Jordan M. Barrows
EGErin D. Goley
Erin D. Goley
To divide, bacteria must synthesize their peptidoglycan (PG) cell wall, a protective meshwork that maintains cell shape. FtsZ, a tubulin homolog, dynamically assembles into a midcell band, recruiting division proteins, including the PG synthases FtsW and FtsI. FtsWI are activated to synthesize PG and drive constriction at the appropriate time and place. However, their activation pathway remains unresolved. In Caulobacter crescentus, FtsWI activity requires FzlA, an essential FtsZ-binding protein. Through time-lapse imaging and single-molecule tracking of Caulobacter FtsW and FzlA, we demonstrate that FzlA is a limiting constriction activation factor that signals to promote conversion of inactive FtsW to an active, slow-moving state. We find that FzlA interacts with the DNA translocase FtsK and place FtsK genetically in a pathway with FzlA and FtsWI. Misregulation of the FzlA-FtsK-FtsWI pathway leads to heightened DNA damage and cell death. We propose that FzlA integrates the FtsZ ring, chromosome segregation, and PG synthesis to ensure robust and timely constriction during Caulobacter division.